Medical Innovation Exchange

Tufts Neurosurgeons Honored for Innovation in Hydrocephalus Treatment



The Society of Vascular and Interventional Neurology (SVIN) has awarded Tufts Medical Center neurosurgeons Adel Malek, M.D., Ph.D., chief of neurovascular surgery, and Carl Heilman, M.D., neurosurgeon-in-chief and chairman of neurosurgery, the 2022 Innovation Award for their work to bring a minimally invasive, endovascular treatment to people with communicating hydrocephalus.

The physicians are co-founders of CereVasc, a clinical-stage, venture-funded, medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases. They developed the company’s flagship product, the eShunt System, which includes an endovascularly implantable cerebral spinal fluid shunt and delivery components, which are designed to treat CH without invasive surgery.

“Drs. Malek and Heilman have developed a disruptive innovation in the eShunt System that has the potential to meaningfully transform the way that patients with communicating hydrocephalus are treated,” said Ameer Hassan, D.O., FAHA, FSVIN, president of SVIN. “SVIN and the neuroendovascular community will benefit greatly from the work they are doing.”

The award was presented during the SVIN annual meeting in November.

Related Articles

  • Sergio Segovia, Apex-Brasil

    Three startup companies have made strong strides in helping patients with autism spectrum disorder.

  • Regenerative Medicine, microencapsulation

    The rise in chronic disease and the effort to reduce healthcare costs presents a large opportunity for the field of regenerative medicine.

  • Joan Koerber-Walker and Maria Fontanazza, economic development in medtech, AdvaMed 2015

    In order to keep innovation and manufacturing in the United States, device companies need federal and local support.

  • Medtech, innovation

    CDRH is urging the development of medical technologies and diagnostic tests that address pain, addiction and diversion.


Original post:

Post publish date:


Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!